SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-001460
Filing Date
2021-01-25
Accepted
2021-01-25 17:17:33
Documents
1
Period of Report
2020-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3250
  Complete submission text file 0001567619-21-001460.txt   4626
Mailing Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015
Business Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015 301-215-7440
Petros Pharmaceuticals, Inc. (Issuer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 ROUTE 9 NORTH SUITE 500 MANALAPAN NJ 07726
Business Address
Arnold Mitchell (Reporting) CIK: 0001841497 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39752 | Film No.: 21550762